Eisai Co (ESAIY)

Currency in USD
7.11
+0.07(+0.99%)
Closed·
ESAIY Scorecard
Full Analysis
Management has been aggressively buying back shares
High dividend Yield
Fair Value
Day's Range
6.887.14
52 wk Range
5.9410.75
Key Statistics
Prev. Close
7.04
Open
6.88
Day's Range
6.88-7.14
52 wk Range
5.94-10.75
Volume
52.95K
Average Volume (3m)
144.38K
1-Year Change
-23.47%
Book Value / Share
19.91
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
ESAIY Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Trading at a high P/E ratio relative to near-term earnings growth

Eisai Co News & Analysis

Show more

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Eisai Co Company Profile

Eisai Co., Ltd. engages in the research and development, manufacture, sale, and import and export of pharmaceuticals in Japan. It offers Dayvigo, for the treatment of insomnia; Lenvima, an anticancer agent/molecular targeted medicine for the treatment of thyroid cancer, renal cell carcinoma in combination with everolimus, and hepatocellular carcinoma; Methycobal for the treatment of peripheral neuropathy; and Halaven, an anticancer agent for the treatment of breast cancer. The company also provides Jyseleca, a janus kinase inhibitor; Elental, a branched-chain amino acid preparation; Goofice and Movicol for chronic constipation; Fycompa, an antiepileptic agent; Pariet, a proton-pump inhibitor; Aricept, for Alzheimer's disease/Dementia with Lewy bodies; and Chocola BB plus for the preparation vitamin B2. It has strategic collaboration with Bristol Myers Squibb for the co-development and co-commercialization of farletuzumab ecteribulin antibody drug conjugate; and a clinical trial collaboration and supply agreement with Medivir for the evaluation of fostrox, a liver-targeted treatment. Eisai Co., Ltd. was formerly known as Nihon Eisai Co., Ltd. and changed its name to Eisai Co., Ltd. in 1955. Eisai Co., Ltd. was incorporated in 1941 and is headquartered in Tokyo, Japan.

Employees
10917

Compare ESAIY to Peers and Sector

Metrics to compare
ESAIY
Peers
Sector
Relationship
P/E Ratio
25.8x20.5x−0.5x
PEG Ratio
0.670.150.00
Price/Book
1.4x1.4x2.6x
Price / LTM Sales
1.5x2.4x3.2x
Upside (Analyst Target)
-7.6%42.0%
Fair Value Upside
Unlock18.1%6.6%Unlock

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 163.76%
Dividend Yield
4.23%
Industry Median 2.83%
Annualised payout
1.08
Paid unevenly
5-Years Growth
-
Growth Streak

Earnings

Latest Release
May 15, 2025
EPS / Forecast
3.36 / --
Revenue / Forecast
188.24B / --
EPS Revisions
Last 90 days

ESAIY Income Statement

People Also Watch

7.7170
SAN
+2.18%
127.90
BIIB
-1.07%
108.74
CRWV
-1.40%
163.47
ARM
-0.55%
150.27
DDOG
-0.33%

FAQ

What Stock Exchange Does Eisai Co Trade On?

Eisai Co is listed and trades on the OTC Markets stock exchange.

What Is the Stock Symbol for Eisai Co?

The stock symbol for Eisai Co is "ESAIY."

What Is the Eisai Co Market Cap?

As of today, Eisai Co market cap is 8.00B.

What Is Eisai Co's Earnings Per Share (TTM)?

The Eisai Co EPS (TTM) is 163.76.

From a Technical Analysis Perspective, Is ESAIY a Buy or Sell?

Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.

How Many Times Has Eisai Co Stock Split?

Eisai Co has split 2 times.

How Many Employees Does Eisai Co Have?

Eisai Co has 10917 employees.

What is the current trading status of Eisai Co (ESAIY)?

As of 30 Jul 2025, Eisai Co (ESAIY) is trading at a price of 7.11, with a previous close of 7.04. The stock has fluctuated within a day range of 6.88 to 7.14, while its 52-week range spans from 5.94 to 10.75.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.